Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    AH-7921 molecular structure

    AH-7921 Stats & Data

    ah7921 AM-7921 am7921
    NPS DataHub
    MW329.27
    FormulaC16H22Cl2N2O
    CAS55154-30-8
    IUPAC3,4-dichloro-N-[[1-(dimethylamino)cyclohexyl]methyl]benzamide
    SMILESCN(C)C1(CCCCC1)CNC(=O)c1ccc(Cl)c(Cl)c1
    InChIKeyJMZROFPPEXCTST-UHFFFAOYSA-N
    Opioids
    Chemical Class Cyclohexylbenzamide
    Psychoactive Class Depressant

    Effect Profile

    Curated + 5 Reports
    Opioid 6.3

    Strong euphoria with moderate itching/nausea, mild pain relief, low sedation

    Euphoria / Warmth×3
    10
    Analgesia×2
    4
    Sedation / Relaxation×1
    3
    Itching / Nausea×1
    7
    Based on reports from:

    Tolerance & Pharmacokinetics

    drugs.wiki

    No tolerance chart. Our decay curves for opioids were estimates, and a curve can make tolerance look longer-lasting than it is, which is the dangerous direction.

    Opioid tolerance drops fast when you stop, and even a few days off can be enough, so a dose that used to be normal can now stop your breathing. Overdose deaths rise sharply after prison, detox or leaving treatment, and tolerance also falls during a hospital stay. After any break, start with a much smaller amount, try a test dose first, don't use alone, and keep naloxone within reach. Alcohol, benzodiazepines, gabapentinoids and other sedatives make an opioid overdose much more likely.

    Sources: FRANK: heroin · National Harm Reduction Coalition · WHO: opioid overdose · Merrall et al. 2010 · Binswanger et al. 2007 · Strang et al. 2003 · FDA 2019: gabapentinoids and breathing

    Experience Report Analysis

    Erowid
    6 Reports
    5 Single-substance
    2011–2015 Date Range
    5 With Age Data
    3 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 6 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 5 of 6
    • Female 1 of 6

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 5 experience reports (5 single-substance Erowid)

    5 Reports
    3 Effects Detected
    2 Positive
    1 Adverse
    0 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 5 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 2

    Euphoria 4 of 5 70%
    Sedation 3 of 5 70%

    Adverse Effects 1

    Nausea 3 of 5 70%

    Form / Preparation

    Most common forms and preparations, as a share of the 4 reports that give one

    Too few reports for bars: these forms come from 4 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 3 of 4
    ← Back to AH-7921